{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology",
    "dc:creator": "WOOD, Paul L",
    "dc:relation": "Neuropsychopharmacology (New York, NY) -- Neuropsychopharmacology (N.Y.N.Y), CODEN NEROEW, ISSN 0893-133X, Vol. 39 (1) , pp. 24-33",
    "dc:date": "2014",
    "dc:type": [
        "Text",
        "Article"
    ],
    "dc:language": "English",
    "dc:publisher": "Nature Publishing Group",
    "dc:format": [
        "print",
        "10 p. ; 2 p.1/4"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Cancer"
        },
        {
            "@xml:lang": "fr",
            "#text": "Gliome malin"
        },
        {
            "@xml:lang": "fr",
            "#text": "Pathologie du système nerveux central"
        },
        {
            "@xml:lang": "fr",
            "#text": "Pathologie du système nerveux"
        },
        {
            "@xml:lang": "fr",
            "#text": "Psychose"
        },
        {
            "@xml:lang": "fr",
            "#text": "Trouble du développement"
        },
        {
            "@xml:lang": "fr",
            "#text": "Tumeur maligne"
        },
        {
            "@xml:lang": "fr",
            "#text": "Autisme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Glioblastome"
        },
        {
            "@xml:lang": "fr",
            "#text": "Métabonomique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Psychiatrie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Schizophrénie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Stratégie"
        },
        {
            "@xml:lang": "en",
            "#text": "Cancer"
        },
        {
            "@xml:lang": "en",
            "#text": "Malignant glioma"
        },
        {
            "@xml:lang": "en",
            "#text": "Central nervous system disease"
        },
        {
            "@xml:lang": "en",
            "#text": "Nervous system diseases"
        },
        {
            "@xml:lang": "en",
            "#text": "Psychosis"
        },
        {
            "@xml:lang": "en",
            "#text": "Developmental disorder"
        },
        {
            "@xml:lang": "en",
            "#text": "Malignant tumor"
        },
        {
            "@xml:lang": "en",
            "#text": "Autism"
        },
        {
            "@xml:lang": "en",
            "#text": "Glioblastoma"
        },
        {
            "@xml:lang": "en",
            "#text": "Metabonomics"
        },
        {
            "@xml:lang": "en",
            "#text": "Psychiatry"
        },
        {
            "@xml:lang": "en",
            "#text": "Schizophrenia"
        },
        {
            "@xml:lang": "en",
            "#text": "Strategy"
        },
        {
            "@xml:lang": "en",
            "#text": "autism"
        },
        {
            "@xml:lang": "en",
            "#text": "glioblastoma"
        },
        {
            "@xml:lang": "en",
            "#text": "metabolomics"
        },
        {
            "@xml:lang": "en",
            "#text": "plasmalogens"
        },
        {
            "@xml:lang": "en",
            "#text": "schizophrenia"
        },
        {
            "@xml:lang": "en",
            "#text": "sulfatides"
        },
        {
            "@xml:lang": "es",
            "#text": "Cáncer"
        },
        {
            "@xml:lang": "es",
            "#text": "Glioma maligno"
        },
        {
            "@xml:lang": "es",
            "#text": "Sistema nervosio central patología"
        },
        {
            "@xml:lang": "es",
            "#text": "Sistema nervioso patología"
        },
        {
            "@xml:lang": "es",
            "#text": "Psicosis"
        },
        {
            "@xml:lang": "es",
            "#text": "Trastorno desarrollo"
        },
        {
            "@xml:lang": "es",
            "#text": "Tumor maligno"
        },
        {
            "@xml:lang": "es",
            "#text": "Autismo"
        },
        {
            "@xml:lang": "es",
            "#text": "Glioblastoma"
        },
        {
            "@xml:lang": "es",
            "#text": "Metabonomica"
        },
        {
            "@xml:lang": "es",
            "#text": "Psiquiatría"
        },
        {
            "@xml:lang": "es",
            "#text": "Esquizofrenia"
        },
        {
            "@xml:lang": "es",
            "#text": "Estrategia"
        },
        "002B04C: Tumeurs multiples. Tumeurs solides. Tumeurs chez l'enfant (généralités) / Multiple tumors. Solid tumors. Tumors in childhood (general aspects)",
        "002B17E: Tumeurs du système nerveux. Phacomatoses / Tumors of the nervous system. Phacomatoses",
        "002B18C06A: Schizophrénie / Schizophrenia",
        "002B18D04B: Autisme infantile / Infantile autism",
        "770-D: PSYCHOPATHOLOGIE. PSYCHIATRIE / Psychopathology. Psychiatry",
        "770-D03F01: Schizophrénie / Schizophrenia",
        "770-D04D02: Autisme infantile / Infantile autism"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 28517750"
}